Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02)

2021-12-01T05:59:50+00:00November 30th, 2021|

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02) Overall survival rate CONTACT US Summary The data aims to examine patients with platinum-sensitive ovarian [...]

Phase I/II clinical trial of modulated electro- hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer

2021-11-14T07:06:16+00:00November 11th, 2021|

Phase I/II clinical trial of modulated electro- hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer Stages of ovarian cancer CONTACT US Summary This [...]

Go to Top